Sarcoidosis
Respiratory·MeSH: Sarcoidosis
Prevalence
30.0 / 100K
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| efzofitimod | aTYR PHARMA INC (ATYR) |
Frequently asked questions
How many drugs are in development for Sarcoidosis?
BioSniper tracks 1 drug in development for Sarcoidosis across 1 company.
How many clinical trials target Sarcoidosis?
There are 2 clinical trials targeting Sarcoidosis tracked by BioSniper.
What is the prevalence of Sarcoidosis?
The estimated prevalence of Sarcoidosis is approximately 30.0 per 100,000 population.
Deep-dive into Sarcoidosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis